HSE100027
25016
isavuconazole
Cresemba®
Indicated in patients from 1 year of age and older for the treatment of invasive aspergillosis, and mucormycosis in patients for whom amphotericin B is inappropriate.
HSE Approval Letter Issued to Applicant
01/11/2025